Deal overview

Deal overview
Target HIKMA PHARMACEUTICALS PLC
Bidder INSTITUTIONAL INVESTORS
Price £80.00 Full version or £25.00 Light version
Publication Date Jun 22, 2020
Abstract On 22 July 2020, the German pharmaceutical group Boehringer Ingelheim Invest GmbH ("Boehringer Ingelheim") announced that it intended to sell approximately 28 million ordinary shares (an 11.51% stake) in Hikma Pharmaceuticals Plc ("Hikma") by way of an accelerated bookbuild offering to institutional investors. Concurrently with the placing, Hikma had committed to buy back ...
Number of pages (Full version) 8
Number of pages (Light version) 2
Format Adobe Acrobat (Download Acrobat Reader)
Free Sample Click Here to Download

Purchase this report

Accepted credit cards: Visa, America Express, Master Card

Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.

Search for Deals

Search over 70 million deal reports on more than 550,000 public and private companies. (copy)

Back to search results

Page Time: 0.013969s